Biomarker Testing Services Market by Services (Biomarker Assay Development & Validation, Flow Cytometry), End-User (Contract Research Oraganizations, Pharmaceutical & biotechnology companies, Research Institutes) - Global Forecast 2024-2030

Biomarker Testing Services Market by Services (Biomarker Assay Development & Validation, Flow Cytometry), End-User (Contract Research Oraganizations, Pharmaceutical & biotechnology companies, Research Institutes) - Global Forecast 2024-2030


The Biomarker Testing Services Market size was estimated at USD 1.48 billion in 2023 and expected to reach USD 1.68 billion in 2024, at a CAGR 15.52% to reach USD 4.07 billion by 2030.

Global Biomarker Testing Services Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biomarker Testing Services Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biomarker Testing Services Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biomarker Testing Services Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Agilent Technologies, Inc., Avid Bioservices, Inc., BioAgilytix Labs, BiomarkerBay B. V., Bristol Myers Squibb, Eurofins Scientific SE, F. Hoffmann-La Roche AG,, Icon PLC, Intertek Group PLC, IQVIA, JSR Life Sciences, LLC, Laboratory Corporation of America Holdings, LGC Group, Merck KGaA, NeoGenomics Laboratories, Parexel International Corporation, SGS S.A., Shuwen Biotech Co., Ltd., Syneos Health, Thermo Fisher Scientific, Inc., and WuXi Biologics Inc..

Market Segmentation & Coverage



This research report categorizes the Biomarker Testing Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

Services
Biomarker Assay Development & Validation
Flow Cytometry
End-User
Contract Research Oraganizations
Pharmaceutical & biotechnology companies
Research Institutes
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biomarker Testing Services Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biomarker Testing Services Market?
3. What are the technology trends and regulatory frameworks in the Biomarker Testing Services Market?
4. What is the market share of the leading vendors in the Biomarker Testing Services Market?
5. Which modes and strategic moves are suitable for entering the Biomarker Testing Services Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Biomarker Testing Services Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing cancer drug development and need for high-performing biomarkers
5.1.1.2. Government initiatives and investments for biomarker research
5.1.1.3. Improved availability of financial coverage for biomarker testing
5.1.2. Restraints
5.1.2.1. Time-consuming and expensive process of biomarker testing
5.1.3. Opportunities
5.1.3.1. Advancements in biomarker testing tools & equipment with AI & ML
5.1.3.2. Emerging CDMOs offering biomarker testing and analysis services
5.1.4. Challenges
5.1.4.1. Barriers in testing due to lack of sample collection and authenticity
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Biomarker Testing Services Market, by Services
6.1. Introduction
6.2. Biomarker Assay Development & Validation
6.3. Flow Cytometry
7. Biomarker Testing Services Market, by End-User
7.1. Introduction
7.2. Contract Research Oraganizations
7.3. Pharmaceutical & biotechnology companies
7.4. Research Institutes
8. Americas Biomarker Testing Services Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Biomarker Testing Services Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Biomarker Testing Services Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abcam PLC
12.1.2. Agilent Technologies, Inc.
12.1.3. Avid Bioservices, Inc.
12.1.4. BioAgilytix Labs
12.1.5. BiomarkerBay B. V.
12.1.6. Bristol Myers Squibb
12.1.7. Eurofins Scientific SE
12.1.8. F. Hoffmann-La Roche AG,
12.1.9. Icon PLC
12.1.10. Intertek Group PLC
12.1.11. IQVIA
12.1.12. JSR Life Sciences, LLC
12.1.13. Laboratory Corporation of America Holdings
12.1.14. LGC Group
12.1.15. Merck KGaA
12.1.16. NeoGenomics Laboratories
12.1.17. Parexel International Corporation
12.1.18. SGS S.A.
12.1.19. Shuwen Biotech Co., Ltd.
12.1.20. Syneos Health
12.1.21. Thermo Fisher Scientific, Inc.
12.1.22. WuXi Biologics Inc.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
FIGURE 1. BIOMARKER TESTING SERVICES MARKET RESEARCH PROCESS
FIGURE 2. BIOMARKER TESTING SERVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. BIOMARKER TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOMARKER TESTING SERVICES MARKET DYNAMICS
FIGURE 7. BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 8. BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 10. BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. BIOMARKER TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. BIOMARKER TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings